105years
（Founded in 1920）
100years
* Over 100 years
Top share in Japan
Leading Company
※In-house estimate
95%
71.1 billion yen
（FY2025）
1632
（End of FY2024）
23
Including 1 international site
8.2％
8.0％
40％
（Benchmark ratio） *Progressive dividend policy adopted *Both policies effective from FY2026
7.0 billion yen
(FY2025) *ASKA Pharmaceutical
Ratio of female employees*1
33.5％
Ratio of female management positions
13.5％
Ratio of female management candidates
20.0％
(End of FY2024 in ASKA Pharmaceutical)
Initiatives to Promote the Advancement of Women
100.0％
（FY2024 in ASKA Pharmaceutical)
53.6％
* The rate in FY2024 compared with the rate in FY2013
Decarbonization Initiatives